Molecular diagnostics laboratory P23 Labs reported on Friday the availability of its new P23 Respiratory ONE test to detect respiratory illnesses that share symptoms with COVID-19 when test results for COVID-19 are negative and the patient is still not healthy.
The company added that the P23 Respiratory ONE can detect the common cold, five different Influenza strains and five Coronavirus strains including COVID-19. The test results are available 48 hours from lab receipt.
According to the company, the P23 Respiratory ONE takes a single COVID-19 sample, whether it is the non-invasive saliva sample or the nasal swab sample. The kits are shipped directly to patients to allow sample collection from the comfort of their own home.
If anyone is presenting COVID-19 symptoms and working with their physician to obtain a COVID-19 order, the patient should also tell their physician that they would like to have a test that identifies what illness they do have if it is not COVID-19, concluded the company.
IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
Novartis to build new radioligand therapy site in Texas
GSK to acquire 35Pharma for USD950m to strengthen cardiopulmonary pipeline
Epredia signs EU distribution deal with Mindpeak for AI pathology software
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH
CStone Pharmaceuticals' sugemalimab granted new indication by UK MHRA
Merck reports positive Phase 3 data for Enflonsia in high-risk children across two RSV seasons